Literature DB >> 20926270

The aryl hydrocarbon receptor: fine-tuning the immune-response.

Marc Veldhoen1, João H Duarte.   

Abstract

Triggers involved in the development of an autoimmune disease, and those that are part of determining its level of severity, are a major focus of current investigative efforts. However, factors that increase the risk to disease may not be similar to those that determine its severity or its pace of progression. The aryl hydrocarbon receptor (AhR) has been highlighted as having a potential regulatory role in these processes. Here we describe the recent findings of the possible involvement of AhR in the initiation and inhibition of immune responses.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926270     DOI: 10.1016/j.coi.2010.09.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  31 in total

1.  Resveratrol and Malignancies.

Authors:  Rodica P Bunaciu; Andrew Yen
Journal:  Curr Pharmacol Rep       Date:  2015-03-10

2.  Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis.

Authors:  Celine A Beamer; Benjamin P Seaver; David M Shepherd
Journal:  Toxicol Sci       Date:  2012-01-23       Impact factor: 4.849

3.  Ikaros sets the potential for Th17 lineage gene expression through effects on chromatin state in early T cell development.

Authors:  Larry Y Wong; Julianne K Hatfield; Melissa A Brown
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

Review 4.  Modulation of the immune system by UV radiation: more than just the effects of vitamin D?

Authors:  Prue H Hart; Shelley Gorman; John J Finlay-Jones
Journal:  Nat Rev Immunol       Date:  2011-08-19       Impact factor: 53.106

5.  The Ah receptor regulates growth factor expression in head and neck squamous cell carcinoma cell lines.

Authors:  Kaarthik John; Tejas S Lahoti; Kelly Wagner; Jarod M Hughes; Gary H Perdew
Journal:  Mol Carcinog       Date:  2013-04-27       Impact factor: 4.784

6.  Activation of the aryl hydrocarbon receptor by TCDD inhibits mammary tumor metastasis in a syngeneic mouse model of breast cancer.

Authors:  Tao Wang; Katie L Wyrick; Gary G Meadows; Tamara B Wills; Beth A Vorderstrasse
Journal:  Toxicol Sci       Date:  2011-09-26       Impact factor: 4.849

7.  Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.

Authors:  Giada Mondanelli; Alice Coletti; Francesco Antonio Greco; Maria Teresa Pallotta; Ciriana Orabona; Alberta Iacono; Maria Laura Belladonna; Elisa Albini; Eleonora Panfili; Francesca Fallarino; Marco Gargaro; Giorgia Manni; Davide Matino; Agostinho Carvalho; Cristina Cunha; Patricia Maciel; Massimiliano Di Filippo; Lorenzo Gaetani; Roberta Bianchi; Carmine Vacca; Ioana Maria Iamandii; Elisa Proietti; Francesca Boscia; Lucio Annunziato; Maikel Peppelenbosch; Paolo Puccetti; Paolo Calabresi; Antonio Macchiarulo; Laura Santambrogio; Claudia Volpi; Ursula Grohmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-05       Impact factor: 11.205

8.  Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection.

Authors:  Fatima Brant; Aline S Miranda; Lisia Esper; David Henrique Rodrigues; Lucas Miranda Kangussu; Daniella Bonaventura; Frederico Marianetti Soriani; Vanessa Pinho; Danielle G Souza; Milene Alvarenga Rachid; Louis M Weiss; Herbert B Tanowitz; Mauro Martins Teixeira; Antônio Lucio Teixeira; Fabiana Simão Machado
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

Review 9.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

10.  A mouse model links asthma susceptibility to prenatal exposure to diesel exhaust.

Authors:  Sarah Manners; Rafeul Alam; David A Schwartz; Magdalena M Gorska
Journal:  J Allergy Clin Immunol       Date:  2013-12-22       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.